Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium fluoride + silica is a combination formulation used in oral hygiene products, specifically toothpaste, developed by GSK for the maintenance of gingival health and the prevention of gingivitis. Sodium fluoride acts as a cariostatic and antibacterial agent by enhancing the remineralization of tooth enamel and inhibiting the metabolism of plaque-forming bacteria through the inhibition of the enzyme enolase. Silica serves as a mild abrasive to mechanically remove dental plaque and surface stains. This specific formulation was evaluated as a comparator in clinical trials investigating experimental anti-gingivitis agents, such as those containing isopropylmethylphenol. The combination is intended to maintain optimum gingival health following professional dental cleaning.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium fluoride + silica.